CSIR-Laxai gets DCGI nod for conducting clinical trials of Colchicine on COVID-19 patients
The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients.
Jun 12, 2021, 13:51 PM IST
This cheap, oral anti-inflammatory drug can reduce COVID severity
An inexpensive, readily available oral anti-inflammatory drug can reduce the risk of hospitalisation and death for some patients with COVID-19, according to a study.
May 31, 2021, 14:46 PM IST